Overview

Bunionectomy Study for Postoperative Analgesia (EPOCH 1)

Status:
Completed
Trial end date:
2018-03-13
Target enrollment:
Participant gender:
Summary
This is a Phase 3, randomized, double-blind, saline placebo- and active-controlled, multicenter study to evaluate the analgesic efficacy and safety of HTX 011 administered via local administration into the surgical site in subjects undergoing bunionectomy.
Phase:
Phase 3
Details
Lead Sponsor:
Heron Therapeutics
Treatments:
Bupivacaine